Geneva, March 20 -- International Clinical Trials Registry received information related to the study (NCT07443592) titled 'Treatment for Ph-negative ALL for Adults up to 65 Years' on Feb. 25.
Study Type: Interventional
Study Design:
Allocation: Non-Randomized. Intervention model: Parallel Assignment. Primary purpose: Treatment. Masking: None (Open Label).
Primary Sponsor: PETHEMA Foundation
Condition:
Acute Lymphoblastic Leukemia
Intervention:
Drug: Pediatric-type of chemotherapy (+blinatumomab for B-cell precursor ALL)
Recruitment Status: Not recruiting
Phase: N/A
Date of First Enrollment: March 6, 2026
Target Sample Size: 330
Countries of Recruitment:
Spain
To know more, visit https://clinicaltrials.gov/study/NCT074435...